Synthesis of multimeric MR contrast agents for cellular imaging
- PMID: 18452288
- PMCID: PMC2755520
- DOI: 10.1021/ja0777990
Synthesis of multimeric MR contrast agents for cellular imaging
Abstract
We have prepared a series of molecular multimeric MR contrast agents for cell labeling that are easy to synthesize, relatively low molecular weight, and biocompatible. The relaxivities of the agents range from 17 to 85 mM(-1) s(-1). Cellular uptake is concentration dependent and viability is excellent. MR images of cell pellets reveal a marked increase in observed signal intensity.
Figures
References
-
- Voisin P, Ribot EJ, Miraux S, Bouzier-Sore AK, Lahitte JF, Bouchaud V, Mornet S, Thiaudiere E, Franconi JM, Raison L, Labrugere C, Delville MH. Bioconjugate Chem. 2007;18:1053–1063. - PubMed
-
- Frullano L, Meade TJ. J Biol Inorg Chem. 2007;12:939–949. - PubMed
-
- Modo MM, Bulte JWW, editors. Molecular and Cellular MR Imaging. CRC Press; Boca Raton, FL: 2007.
-
- Merbach AE, Toth E, editors. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. 1. Wiley; New York: 2001.
-
-
Recent reports cite NSF toxicity exclusively in patients with renal failure with one class of DTPA Gd(III) chelate and has prompted studies validating the in vivo stability and safety of Gd(III) agents: Kurtkoti J, Snow T, Hiremagalur B. Nephrology. 2008;13:235–241.Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Am J Roentgenol. 2007;189:1533–1538.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
